MIMS Full Prescribing Update
New / Revised |
Product Name |
Section changed |
---|---|---|
New | Adrenal RX | |
New | ANSTO Health Chromium (51Cr) Edetate Injection BP | |
New | Anthelios Sunscreens | |
New | APO-Levodopa/Carbidopa | |
New | Ares | |
New | Bimtop | |
New | BTC Perindopril | |
New | CeraVe Renewing SA Foot Cream | |
New | CeraVe Reparative Hand Cream | |
New | Cipla Pregabalin | |
New | Easy Day Multi-action Eye Spray | |
New | Esberitox | |
New | EzSimva GH | |
New | Fulphila | |
New | Glycopyrrolate Accord | |
New | Immune RX | |
New | La Roche-Posay Hyalu B5 | |
New | La Roche-Posay Pigmentclar | |
New | La Roche-Posay Redermic | |
New | La Roche-Posay Rosaliac AR Intense | |
New | Lacteeze Ultra | |
New | Moxotens | |
New | Mylanta 2go Antacid FastChews | |
New | Nepro HP | |
New | Nubeqa | |
New | PediaSure Fibre | |
New | Perindopril APOTEX | |
New | Proctosedyl Witch Hazel | |
New | Seroflo | |
New | Sevelamer Lupin | |
New | Sudafed Xylo Nasal Decongestant | |
New | Systane Complete | |
New | Trazimera | |
New | Venus E-Tox | |
New | Yescarta | |
New | Z-Mag | |
Reinstated | Dilart HCT | |
Revised | Aclasta | Effects on Ability to Drive and Use Machines, Special Precautions for Storage |
Revised | Adcetris | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use, Sponsor, Therapeutic Indications |
Revised | Adempas | Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Airomir Autohaler and Inhaler | TGA Date |
Revised | Alkeran | TGA Date |
Revised | Alkeran Injection | TGA Date |
Revised | Alustal | TGA Date |
Revised | APO-Lamotrigine | List of Excipients |
Revised | APO-Lansoprazole ODT | Dose and Method of Administration, Interactions with Other Medicines, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | APO-Latanoprost | Adverse Effects (Undesirable Effects) |
Revised | APO-Pramipexole ER | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | APO-Prazosin | Physicochemical Properties |
Revised | APO-Teriflunomide | Adverse Effects (Undesirable Effects) |
Revised | APO-Ziprasidone | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Arcoxia | TGA Date |
Revised | Aspalgin | Qualitative and Quantitative Composition, Sponsor |
Revised | Aspen Codeine | Boxed Warnings, Contraindications, Indications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Avelox | TGA Date |
Revised | Bavencio | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Biktarvy | Adverse Effects (Undesirable Effects) |
Revised | Boostrix-IPV | Fertility, Pregnancy and Lactation, Pharmacological Properties |
Revised | Bricanyl Turbuhaler | Dose and Method of Administration, Effects on Ability to Drive and Use Machines, List of Excipients, Nature and Contents of Container, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Calcium Chloride Injection (Phebra) | Special Precautions for Storage |
Revised | Camptosar | Dose and Method of Administration, Fertility, Pregnancy and Lactation |
Revised | CAPD/DPCA Sleep Safe | Adverse Effects (Undesirable Effects), List of Excipients, Nature and Contents of Container, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | CAPD/DPCA Stay Safe | Adverse Effects (Undesirable Effects), List of Excipients, Nature and Contents of Container, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Carboplatin Accord | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Celebrex | Special Warnings and Precautions for Use |
Revised | Cephalex | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Clonac | Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | CMV Immunoglobulin-VF | Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Colese | TGA Date |
Revised | Colgout | TGA Date |
Revised | Colofac | TGA Date |
Revised | Cosentyx | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties |
Revised | Creon Capsules | Adverse Effects (Undesirable Effects), Pharmacological Properties, Physicochemical Properties |
Revised | Cubicin | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Darzalex | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New indication, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | DBL Ciprofloxacin Injection For Intravenous Infusion | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | DBL Irinotecan Injection Concentrate | Fertility, Pregnancy and Lactation |
Revised | DBL Vinblastine Injection | Physicochemical Properties |
Revised | Denpax | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Depo-Provera | Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Depo-Ralovera | Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Elonva | Overdose, Special Warnings and Precautions for Use |
Revised | Emend IV | TGA Date |
Revised | Ensure Plus HN | Contraindications, Dose and Method of Administration, Name of Medicine, Presentation, Qualitative and Quantitative Composition, Special Precautions for Storage, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Epilim | Fertility, Pregnancy and Lactation |
Revised | Epilim IV | Fertility, Pregnancy and Lactation |
Revised | Ertapenem Kabi | TGA Date |
Revised | Esomeprazole AN Powder for Injection | TGA Date |
Revised | Evicel | TGA Date |
Revised | Famvir | Sponsor |
Revised | Feldene, Feldene-D | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Femme-Tab ED 20/100 | Effects on Ability to Drive and Use Machines, Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Fenofibrate Cipla | TGA Date |
Revised | Ferinject | Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Ferro-grad C | Product Name change, Sponsor |
Revised | Florinef | Effects on Ability to Drive and Use Machines |
Revised | Fluconazole Sandoz | Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Fluconazole Sandoz Injection | Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Flumazenil-Baxter | Special Precautions for Storage |
Revised | Fluorescite | Product Name change, TGA Date |
Revised | Fluticasone + Salmeterol Cipla | Product Name change, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Folic Acid Injection 5 mg in 1 mL | Nature and Contents of Container |
Revised | Forxiga | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Fragmin | Special Warnings and Precautions for Use |
Revised | Fucidin | Special Warnings and Precautions for Use |
Revised | Fycompa | TGA Date |
Revised | Gapentin Tablets | TGA Date |
Revised | Gastrogel Antacid | Sponsor |
Revised | Genvoya | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Glucerna | Dosage and Administration, Precautions, Presentation |
Revised | Granocyte | Special Warnings and Precautions for Use |
Revised | Hequinel | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Humulin Preparations | TGA Date |
Revised | Hydromorphone JUNO/ JUNO-HP/ JUNO-XHP | TGA Date |
Revised | Imrest | Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Infanrix-IPV | TGA Date |
Revised | Intragam 10 | Adverse Effects (Undesirable Effects), Overdose, Pharmacological Properties, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Kogenate FS (with vial adapter) | TGA Date |
Revised | Latanoprost Sandoz | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Lengout | TGA Date |
Revised | Lidocaine-Baxter | Product Name change, Sponsor, TGA Date |
Revised | Lincocin | TGA Date |
Revised | Lorano | TGA Date |
Revised | Luvox | Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use |
Revised | Lyzalon | Pharmacological Properties |
Revised | MabThera SC | Fertility, Pregnancy and Lactation |
Revised | Merieux Inactivated Rabies Vaccine | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Pharmacological Properties, Shelf Life, Special Warnings and Precautions for Use |
Revised | Mersyndol DayStrength | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Microshield 2 | Adverse Effects, Dosage and Administration, Indications, Interactions with Other Medicines, Precautions |
Revised | Microshield 4 | Adverse Effects, Dosage and Administration, Indications, Interactions with Other Medicines, Precautions |
Revised | Microshield 5 | Adverse Effects, Dosage and Administration, Indications, Interactions with Other Medicines, Precautions |
Revised | Microshield Handrub | Adverse Effects, Dosage and Administration, Indications, Interactions with Other Medicines, Precautions |
Revised | Microshield T | Dosage and Administration, Indications, Interactions with Other Medicines, Precautions |
Revised | Midazolam Accord | Nature and Contents of Container |
Revised | Minidiab | TGA Date |
Revised | Minims Amethocaine Eye Drops | TGA Date |
Revised | Minims Atropine Eye Drops | TGA Date |
Revised | Minims Lidocaine (Lignocaine) and Fluorescein | Product Name change, TGA Date |
Revised | Mirtanza | List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Physicochemical Properties, Special Precautions for Storage, Sponsor |
Revised | Mirtazapine GH | Adverse Effects (Undesirable Effects) |
Revised | Mirtazapine Sandoz | Adverse Effects (Undesirable Effects) |
Revised | Mirtazapine Sandoz ODT | Adverse Effects (Undesirable Effects) |
Revised | MonoFIX-VF 100 IU/mL | Nature and Contents of Container |
Revised | MonoFIX-VF 50 IU/mL | Nature and Contents of Container |
Revised | Movox | Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use |
Revised | Mydriacyl | TGA Date |
Revised | Naprogesic | Adverse Effects, Contraindications, Dose and Method of Administration, Indications, Interactions with Other Medicines, Precautions |
Revised | Neutrogena T/Gel Therapeutic Shampoo | Adverse Effects, Dosage and Administration, Indications, Precautions |
Revised | Nimotop | TGA Date |
Revised | Nivestim | Incompatibilities, Special Precautions for Storage |
Revised | Normal Immunoglobulin-VF | TGA Date |
Revised | Odefsey | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Ondansetron Alphapharm | Fertility, Pregnancy and Lactation |
Revised | Ondansetron APOTEX | Fertility, Pregnancy and Lactation |
Revised | Opdivo | Dose and Method of Administration, Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Orgaran | TGA Date |
Revised | Osteovan | Qualitative and Quantitative Composition, Shelf Life |
Revised | Ovestin Ovula | TGA Date |
Revised | Panadeine Forte | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Panamax Co | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Pantoprazole MYL | Product Name change |
Revised | Paracetamol Kabi | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Pfizer (Perth) Chlorhexidine Irrigation Solution | Product Name change |
Revised | Pharmacor Mycophenolate 250 | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Pharmacor Olmesartan HCTZ | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Pharmacor Telmisartan | Shelf Life |
Revised | Plaquenil | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Prodeine | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Prodeine Forte | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Prodeinextra | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Proladone | Boxed Warnings, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use |
Revised | Provera | Effects on Ability to Drive and Use Machines, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Quilonum SR | Adverse Effects (Undesirable Effects), Nature and Contents of Container, Physicochemical Properties |
Revised | Ralovera | Effects on Ability to Drive and Use Machines, List of Excipients, Nature and Contents of Container, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Reminyl | TGA Date |
Revised | Revestive | Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Rh(D) Immunoglobulin-VF | TGA Date |
Revised | Ridaura | TGA Date |
Revised | Segluromet | Contraindications, Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | Simpral | Adverse Effects (Undesirable Effects) |
Revised | Sinemet | Dose and Method of Administration, List of Excipients, Nature and Contents of Container, Pharmaceutical Form |
Revised | Sintetica Baclofen Intrathecal | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Sleep Safe Balance | Adverse Effects (Undesirable Effects), List of Excipients, Special Warnings and Precautions for Use |
Revised | Sodium Valproate Sandoz | Fertility, Pregnancy and Lactation |
Revised | Stay Safe Balance | Adverse Effects (Undesirable Effects), List of Excipients, Special Warnings and Precautions for Use |
Revised | Stildem | Contraindications, Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, Overdose, Special Warnings and Precautions for Use |
Revised | Synacthen | Sponsor |
Revised | Synacthen Depot | List of Excipients |
Revised | Technescan HDP | Dose and Method of Administration, Special Precautions for Storage |
Revised | Temtabs | List of Excipients, Qualitative and Quantitative Composition |
Revised | Tenofovir Disoproxil Emtricitabine Mylan 300/200 | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions |
Revised | Tenofovir Disoproxil Mylan | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Tetanus Immunoglobulin-VF (For Intramuscular Use) | Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Tetanus Immunoglobulin-VF (For Intravenous Use) | Fertility, Pregnancy and Lactation |
Revised | Topiramate Sandoz | Special Warnings and Precautions for Use |
Revised | Tysabri | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Valpro EC | Fertility, Pregnancy and Lactation |
Revised | Valproate Winthrop | Fertility, Pregnancy and Lactation |
Revised | Venclexta | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Vfend | TGA Date |
Revised | Viramune | Deleted Presentation, Nature and Contents of Container, Pharmaceutical Form |
Revised | Voriconazole APOTEX Powder for Injection | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Special Warnings and Precautions for Use |
Revised | Xigduo XR | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Zolfend IV | Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Zometa | Nature and Contents of Container, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Zoster Immunoglobulin-VF | TGA Date |
Revised | Zumenon | Effects on Ability to Drive and Use Machines |
Deleted | Auro-Mirtazapine | |
Deleted | Esberitox N | |
Deleted | Meridian Blood Glucose Control | |
Deleted | Meridian Blood Glucose Test Strips | |
Deleted | Murine Eye Drops | |
Deleted | Murine Revital Eyes | |
Deleted | Omnitest Sensor |
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Suite 302, Level 3, 53 Berry Street
North Sydney NSW 2060
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au